Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure
Hypertension Research 38,
123 (February 2015). doi:10.1038/hr.2014.148
Authors: Jie Peng, Yingxin Zhao, Hua Zhang, Zhendong Liu, Zhihao Wang, Mengxiong Tang, Ming Zhong, Fanghong Lu & Wei Zhang
Source: Hypertension Research - Category: Cardiology Authors: Jie PengYingxin ZhaoHua ZhangZhendong LiuZhihao WangMengxiong TangMing ZhongFanghong LuWei Zhang Tags: abdominal obesity high-normal blood pressure metabolic syndrome pharmacoeconomics Source Type: research
More News: Cardiology | Eating Disorders & Weight Management | Hypertension | Indapamide | Men | Metabolic Syndrome | Obesity